๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Status
Unknown
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2019-09-15
Trial ID
NCT04143191
Treatments Being Tested
This trial is designed to be the initial prospective pilot investigation of...
Status
Active Not Recruiting
Location
Loyola University Medical Center
Start Date
2013-07
Trial ID
NCT01918683
Treatments Being Tested
This is a multicenter, Phase I/II study in patients with non-resectable hep...
Status
Recruiting
Location
National Taiwan University Hospital
Start Date
2020-10-06
Trial ID
NCT03812874
Treatments Being Tested
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in...
Status
Unknown
Location
The Fourth Affiliated Hospital of Haerbin Medical University
Start Date
2009-08
Trial ID
NCT00960518
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-05
Trial ID
NCT00335829
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of sintilimab-be...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-30
Trial ID
NCT07522411
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Status
Unknown
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-09-01
Trial ID
NCT04127396
Hepatocellular carcinoma (HCC) is listed as the sixth most common cancer wo...
Status
Unknown
Location
Sohag University Hospital
Start Date
2022-01-01
Trial ID
NCT05093920
Treatments Being Tested
The purpose of this study is to determine the maximal tolerated dose of ida...
Status
Completed
Location
Centre Hospitalier Universitaire de DIJON
Start Date
2009-12
Trial ID
NCT01040559
Treatments Being Tested
This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2025-04-01
Trial ID
NCT06904183
Treatments Being Tested